Study assessing symptoms of anxiety, depression and sleep quality disturbances in post-Covid-19 Mucormycosis patients admitted for in-patient treatment admitted at a tertiary care hospital

Background: Mucormycosis (previously : zygomycosis) is a rare and serious fungal infection caused by a group of molds called mucormycetes. There are five major clinical forms of Mucormycosis; gastrointestinal, disseminated, rhinocerebral , cutaneous and pulmonary, of which the latter 3 are the most...

Full description

Saved in:
Bibliographic Details
Published in:Indian journal of psychiatry 2022-03, Vol.64 (Suppl 3), p.S527-S527
Main Author: Nair, Aditya S
Format: Article
Language:English
Subjects:
Analysis
Care and treatment
Depression, Mental
Diagnosis
Health aspects
Mucormycosis
Prof K C Dube Poster Award
Sleep
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites
container_end_page S527
container_issue Suppl 3
container_start_page S527
container_title Indian journal of psychiatry
container_volume 64
creator Nair, Aditya S
description Background: Mucormycosis (previously : zygomycosis) is a rare and serious fungal infection caused by a group of molds called mucormycetes. There are five major clinical forms of Mucormycosis; gastrointestinal, disseminated, rhinocerebral , cutaneous and pulmonary, of which the latter 3 are the most common.There have been no studies conducted on the association of anxiety and depression with Mucormycosis. Materials and Methods : 50 sample size. Conducted in the special Mucormycosis ward at DY Patil Hospital. Scales used were HADS and GSQS. Assessment done on Day5 and Day15 of admission. Results: 50 post-Covid-19 Mucormycosis patients were analysed. 31 patients were males, whereas 19 patients were females. The age group was 18-70.Out of the 50 patients, 32 had Cutaneous type of Mucormycosis; 15 had Pulmonary type of Mucormycosis and 3 had Rhinocerebral type of Mucormycosis. HADS Score was significantly higher on Day 15 (21.02 ± 8.35; P = 0.0000) as compared to Day 5 (17.0 ± 7.69; P = 0.0000) in all patients. GSQS Score was significantly higher on Day 15 (7.10 ± 3.04; P = 0.0000) as compared to Day 5 (4.34 ± 2.80; P = 0.0000) in all patients. Conclusion: Anxiety and Depressive symptoms , along with sleep quality impairment was observed in patients of post-Covid-19 Mucormycosis. Keywords: Mucormycosis, Anxiety, Depression
doi_str_mv 10.4103/0019-5545.341503
format article
fullrecord <record><control><sourceid>gale_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9129843</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A818074879</galeid><sourcerecordid>A818074879</sourcerecordid><originalsourceid>FETCH-LOGICAL-g1533-190a17383d60eb3feeab17b4145987a3c8039833d8a082def0114460894278b13</originalsourceid><addsrcrecordid>eNptkUGLFDEQhRtRcFy9ewwInuwxmaSnk4uwDKsrrHhQz011Uj0T6XTaVHrZ_m_-OLPssuyC5JCi3vceD6qq3gq-VYLLj5wLUzeNarZSiYbLZ9VGGKNr2Rr1vNo8yC-rV0S_Od_tVdNuqr8_8uJWBkRI5KcjozXMOQZicWAw3XjM6wfmcE63epzKzjEaEWf2Z4HR55U5T3lJPUwWifmJzZFyfYjX3tXCsG-LjSmsNpInNkP2OGVi4ILPGR0bYiqe-l5gOSHkcDs9EFBmljFlD2llFhKyU6TZZxhfVy8GGAnf3P9n1a_PFz8Pl_XV9y9fD-dX9VE0UpYWHEQrtXR7jr0cEKEXba-EaoxuQVrNpdFSOg1c7xwOXAil9lwbtWt1L-RZ9ekud176gM6WfgnGbk4-lE5dBN89VSZ_6o7xujNiZ7SSJeDdXcARRuz8NMSC2eDJdudaaN4q3ZpCbf9DlecweBsnHHzZPzG8f2Q4IYz5RHFccjkUPQb_ASilrPg</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Study assessing symptoms of anxiety, depression and sleep quality disturbances in post-Covid-19 Mucormycosis patients admitted for in-patient treatment admitted at a tertiary care hospital</title><source>Publicly Available Content Database</source><source>PubMed Central</source><source>Medknow Medical Journals (Open access)</source><creator>Nair, Aditya S</creator><creatorcontrib>Nair, Aditya S</creatorcontrib><description>Background: Mucormycosis (previously : zygomycosis) is a rare and serious fungal infection caused by a group of molds called mucormycetes. There are five major clinical forms of Mucormycosis; gastrointestinal, disseminated, rhinocerebral , cutaneous and pulmonary, of which the latter 3 are the most common.There have been no studies conducted on the association of anxiety and depression with Mucormycosis. Materials and Methods : 50 sample size. Conducted in the special Mucormycosis ward at DY Patil Hospital. Scales used were HADS and GSQS. Assessment done on Day5 and Day15 of admission. Results: 50 post-Covid-19 Mucormycosis patients were analysed. 31 patients were males, whereas 19 patients were females. The age group was 18-70.Out of the 50 patients, 32 had Cutaneous type of Mucormycosis; 15 had Pulmonary type of Mucormycosis and 3 had Rhinocerebral type of Mucormycosis. HADS Score was significantly higher on Day 15 (21.02 ± 8.35; P = 0.0000) as compared to Day 5 (17.0 ± 7.69; P = 0.0000) in all patients. GSQS Score was significantly higher on Day 15 (7.10 ± 3.04; P = 0.0000) as compared to Day 5 (4.34 ± 2.80; P = 0.0000) in all patients. Conclusion: Anxiety and Depressive symptoms , along with sleep quality impairment was observed in patients of post-Covid-19 Mucormycosis. Keywords: Mucormycosis, Anxiety, Depression</description><identifier>ISSN: 0019-5545</identifier><identifier>EISSN: 1998-3794</identifier><identifier>DOI: 10.4103/0019-5545.341503</identifier><language>eng</language><publisher>India: Medknow Publications and Media Pvt. Ltd</publisher><subject>Analysis ; Care and treatment ; Depression, Mental ; Diagnosis ; Health aspects ; Mucormycosis ; Prof K C Dube Poster Award ; Sleep</subject><ispartof>Indian journal of psychiatry, 2022-03, Vol.64 (Suppl 3), p.S527-S527</ispartof><rights>COPYRIGHT 2022 Medknow Publications and Media Pvt. Ltd.</rights><rights>Copyright: © 2022 Indian Journal of Psychiatry 2022</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC9129843/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC9129843/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,27924,27925,53791,53793</link.rule.ids></links><search><creatorcontrib>Nair, Aditya S</creatorcontrib><title>Study assessing symptoms of anxiety, depression and sleep quality disturbances in post-Covid-19 Mucormycosis patients admitted for in-patient treatment admitted at a tertiary care hospital</title><title>Indian journal of psychiatry</title><description>Background: Mucormycosis (previously : zygomycosis) is a rare and serious fungal infection caused by a group of molds called mucormycetes. There are five major clinical forms of Mucormycosis; gastrointestinal, disseminated, rhinocerebral , cutaneous and pulmonary, of which the latter 3 are the most common.There have been no studies conducted on the association of anxiety and depression with Mucormycosis. Materials and Methods : 50 sample size. Conducted in the special Mucormycosis ward at DY Patil Hospital. Scales used were HADS and GSQS. Assessment done on Day5 and Day15 of admission. Results: 50 post-Covid-19 Mucormycosis patients were analysed. 31 patients were males, whereas 19 patients were females. The age group was 18-70.Out of the 50 patients, 32 had Cutaneous type of Mucormycosis; 15 had Pulmonary type of Mucormycosis and 3 had Rhinocerebral type of Mucormycosis. HADS Score was significantly higher on Day 15 (21.02 ± 8.35; P = 0.0000) as compared to Day 5 (17.0 ± 7.69; P = 0.0000) in all patients. GSQS Score was significantly higher on Day 15 (7.10 ± 3.04; P = 0.0000) as compared to Day 5 (4.34 ± 2.80; P = 0.0000) in all patients. Conclusion: Anxiety and Depressive symptoms , along with sleep quality impairment was observed in patients of post-Covid-19 Mucormycosis. Keywords: Mucormycosis, Anxiety, Depression</description><subject>Analysis</subject><subject>Care and treatment</subject><subject>Depression, Mental</subject><subject>Diagnosis</subject><subject>Health aspects</subject><subject>Mucormycosis</subject><subject>Prof K C Dube Poster Award</subject><subject>Sleep</subject><issn>0019-5545</issn><issn>1998-3794</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><recordid>eNptkUGLFDEQhRtRcFy9ewwInuwxmaSnk4uwDKsrrHhQz011Uj0T6XTaVHrZ_m_-OLPssuyC5JCi3vceD6qq3gq-VYLLj5wLUzeNarZSiYbLZ9VGGKNr2Rr1vNo8yC-rV0S_Od_tVdNuqr8_8uJWBkRI5KcjozXMOQZicWAw3XjM6wfmcE63epzKzjEaEWf2Z4HR55U5T3lJPUwWifmJzZFyfYjX3tXCsG-LjSmsNpInNkP2OGVi4ILPGR0bYiqe-l5gOSHkcDs9EFBmljFlD2llFhKyU6TZZxhfVy8GGAnf3P9n1a_PFz8Pl_XV9y9fD-dX9VE0UpYWHEQrtXR7jr0cEKEXba-EaoxuQVrNpdFSOg1c7xwOXAil9lwbtWt1L-RZ9ekud176gM6WfgnGbk4-lE5dBN89VSZ_6o7xujNiZ7SSJeDdXcARRuz8NMSC2eDJdudaaN4q3ZpCbf9DlecweBsnHHzZPzG8f2Q4IYz5RHFccjkUPQb_ASilrPg</recordid><startdate>20220301</startdate><enddate>20220301</enddate><creator>Nair, Aditya S</creator><general>Medknow Publications and Media Pvt. Ltd</general><general>Wolters Kluwer - Medknow</general><scope>5PM</scope></search><sort><creationdate>20220301</creationdate><title>Study assessing symptoms of anxiety, depression and sleep quality disturbances in post-Covid-19 Mucormycosis patients admitted for in-patient treatment admitted at a tertiary care hospital</title><author>Nair, Aditya S</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-g1533-190a17383d60eb3feeab17b4145987a3c8039833d8a082def0114460894278b13</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Analysis</topic><topic>Care and treatment</topic><topic>Depression, Mental</topic><topic>Diagnosis</topic><topic>Health aspects</topic><topic>Mucormycosis</topic><topic>Prof K C Dube Poster Award</topic><topic>Sleep</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Nair, Aditya S</creatorcontrib><collection>PubMed Central (Full Participant titles)</collection><jtitle>Indian journal of psychiatry</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Nair, Aditya S</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Study assessing symptoms of anxiety, depression and sleep quality disturbances in post-Covid-19 Mucormycosis patients admitted for in-patient treatment admitted at a tertiary care hospital</atitle><jtitle>Indian journal of psychiatry</jtitle><date>2022-03-01</date><risdate>2022</risdate><volume>64</volume><issue>Suppl 3</issue><spage>S527</spage><epage>S527</epage><pages>S527-S527</pages><issn>0019-5545</issn><eissn>1998-3794</eissn><abstract>Background: Mucormycosis (previously : zygomycosis) is a rare and serious fungal infection caused by a group of molds called mucormycetes. There are five major clinical forms of Mucormycosis; gastrointestinal, disseminated, rhinocerebral , cutaneous and pulmonary, of which the latter 3 are the most common.There have been no studies conducted on the association of anxiety and depression with Mucormycosis. Materials and Methods : 50 sample size. Conducted in the special Mucormycosis ward at DY Patil Hospital. Scales used were HADS and GSQS. Assessment done on Day5 and Day15 of admission. Results: 50 post-Covid-19 Mucormycosis patients were analysed. 31 patients were males, whereas 19 patients were females. The age group was 18-70.Out of the 50 patients, 32 had Cutaneous type of Mucormycosis; 15 had Pulmonary type of Mucormycosis and 3 had Rhinocerebral type of Mucormycosis. HADS Score was significantly higher on Day 15 (21.02 ± 8.35; P = 0.0000) as compared to Day 5 (17.0 ± 7.69; P = 0.0000) in all patients. GSQS Score was significantly higher on Day 15 (7.10 ± 3.04; P = 0.0000) as compared to Day 5 (4.34 ± 2.80; P = 0.0000) in all patients. Conclusion: Anxiety and Depressive symptoms , along with sleep quality impairment was observed in patients of post-Covid-19 Mucormycosis. Keywords: Mucormycosis, Anxiety, Depression</abstract><cop>India</cop><pub>Medknow Publications and Media Pvt. Ltd</pub><doi>10.4103/0019-5545.341503</doi><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0019-5545
ispartof Indian journal of psychiatry, 2022-03, Vol.64 (Suppl 3), p.S527-S527
issn 0019-5545
1998-3794
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9129843
source Publicly Available Content Database; PubMed Central; Medknow Medical Journals (Open access)
subjects Analysis
Care and treatment
Depression, Mental
Diagnosis
Health aspects
Mucormycosis
Prof K C Dube Poster Award
Sleep
title Study assessing symptoms of anxiety, depression and sleep quality disturbances in post-Covid-19 Mucormycosis patients admitted for in-patient treatment admitted at a tertiary care hospital
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-05T19%3A49%3A20IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Study%20assessing%20symptoms%20of%20anxiety,%20depression%20and%20sleep%20quality%20disturbances%20in%20post-Covid-19%20Mucormycosis%20patients%20admitted%20for%20in-patient%20treatment%20admitted%20at%20a%20tertiary%20care%20hospital&rft.jtitle=Indian%20journal%20of%20psychiatry&rft.au=Nair,%20Aditya%20S&rft.date=2022-03-01&rft.volume=64&rft.issue=Suppl%203&rft.spage=S527&rft.epage=S527&rft.pages=S527-S527&rft.issn=0019-5545&rft.eissn=1998-3794&rft_id=info:doi/10.4103/0019-5545.341503&rft_dat=%3Cgale_pubme%3EA818074879%3C/gale_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-g1533-190a17383d60eb3feeab17b4145987a3c8039833d8a082def0114460894278b13%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_id=info:pmid/&rft_galeid=A818074879&rfr_iscdi=true